Michel Adamina
Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288)
Cavazza A, Marini M, Spagnoli G, Adamina M, Roda L. Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288). ChemMedChem 2006; 1:816-20.
Aug 1, 2006Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288)
Aug 1, 2006ChemMedChem 2006; 1:816-20
Cavazza Antonella, Marini Mario, Spagnoli Giulio C, Adamina Michel, Roda L Giorgio
Propensity scores and the surgeon
Adamina M, Guller U, Weber W, Oertli D. Propensity scores and the surgeon. Br J Surg 2006; 93:389-94.
Apr 1, 2006Propensity scores and the surgeon
Apr 1, 2006Br J Surg 2006; 93:389-94
Adamina Michel, Guller U, Weber W P, Oertli D
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Adamina M, Oertli D, Spagnoli G, Amacker M, Zurbriggen R, Feder C, Groeper C, Rosenthal R, Weber W, Zajac P, Schumacher R, Heberer M. Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy. J Liposome Res 2006; 16:195-204.
Jan 1, 2006Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Jan 1, 2006J Liposome Res 2006; 16:195-204
Adamina Michel, Oertli Daniel, Spagnoli Giulio C, Amacker Mario, Zurbriggen Rinaldo, Feder Chantal, Groeper Célia, Rosenthal Rachel, Weber Walter P, Zajac Paul, Schumacher Reto, Heberer Michael
Intractable abdominal pain following laparoscopic adjustable gastric banding
Daetwiler S, Adamina M, Schöb O. Intractable abdominal pain following laparoscopic adjustable gastric banding. Obes Surg 2005; 15:1341-3.
Oct 1, 2005Intractable abdominal pain following laparoscopic adjustable gastric banding
Oct 1, 2005Obes Surg 2005; 15:1341-3
Daetwiler Silvia, Adamina Michel, Schöb Othmar
Clinical applications of recombinant virus-based cancer immunotherapy
Adamina M, Daetwiler S, Rosenthal R, Zajac P. Clinical applications of recombinant virus-based cancer immunotherapy. Expert Opin Biol Ther 2005; 5:1211-24.
Sep 1, 2005Clinical applications of recombinant virus-based cancer immunotherapy
Sep 1, 2005Expert Opin Biol Ther 2005; 5:1211-24
Adamina Michel, Daetwiler Silvia, Rosenthal Rachel, Zajac Paul
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro
Schumacher R, Amacker M, Neuhaus D, Rosenthal R, Groeper C, Heberer M, Spagnoli G, Zurbriggen R, Adamina M. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro. Vaccine 2005; 23:5572-82.
Aug 15, 2005Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro
Aug 15, 2005Vaccine 2005; 23:5572-82
Schumacher Reto, Amacker Mario, Neuhaus Danielle, Rosenthal Rachel, Groeper Célia, Heberer Michael, Spagnoli Giulio C, Zurbriggen Rinaldo, Adamina Michel
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
von Holzen U, Heberer M, Oertli D, Marti W, Schumacher R, Feder C, Reschner A, Groeper C, Zajac P, Weber W, Bolli M, Adamina M, Spagnoli G. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy. Int J Cancer 2005; 115:248-55.
Jun 10, 2005Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
Jun 10, 2005Int J Cancer 2005; 115:248-55
von Holzen Urs, Heberer Michael, Oertli Daniel, Marti Walter, Schumacher Reto, Feder Chantal, Reschner Anca, Groeper Célia, Zajac Paul, Weber Walter P, Bolli Martin, Adamina Michel, Spagnoli Giulio C
Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Spagnoli G, Adamina M, Bolli M, Weber W, Zajac P, Marti W, Oertli D, Heberer M, Harder F. Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation. World J Surg 2005; 29:692-9.
Jun 1, 2005Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Jun 1, 2005World J Surg 2005; 29:692-9
Spagnoli Giulio C, Adamina Michel, Bolli Martin, Weber Walter P, Zajac Paul, Marti Walter, Oertli Daniel, Heberer Michael, Harder Felix
Antigen specific active immunotherapy: lessons from the first decade
Adamina M, Oertli D. Antigen specific active immunotherapy: lessons from the first decade. Swiss Med Wkly 2005; 135:212-21.
Apr 16, 2005Antigen specific active immunotherapy: lessons from the first decade
Apr 16, 2005Swiss Med Wkly 2005; 135:212-21
Adamina Michel, Oertli Daniel
Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells
Cavazza A, Adamina M, Ausiello C, Giardina B, Marini M, Palazzo R, Roda L, Spagnoli G. Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells. Clin Immunol 2004; 111:252-61.
Jun 1, 2004Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells
Jun 1, 2004Clin Immunol 2004; 111:252-61
Cavazza Antonella, Adamina Michel, Ausiello Clara M, Giardina Bruno, Marini Mario, Palazzo Raffaella, Roda L Giorgio, Spagnoli Giulio C
Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation
Schumacher R, Adamina M, Zurbriggen R, Bolli M, Padovan E, Zajac P, Heberer M, Spagnoli G. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation. Vaccine 2004; 22:714-23.
Jan 26, 2004Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation
Jan 26, 2004Vaccine 2004; 22:714-23
Schumacher Reto, Adamina Michel, Zurbriggen Rinaldo, Bolli Martin, Padovan Elisabetta, Zajac Paul, Heberer Michael, Spagnoli Giulio C
Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
Adamina M, Heberer M, Oertli D, Marti W, Feder C, Reschner A, Schumacher R, Padovan E, Zajac P, Cavazza A, Albo F, Bolli M, Spagnoli G. Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes. Br J Cancer 2004; 90:263-9.
Jan 12, 2004Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
Jan 12, 2004Br J Cancer 2004; 90:263-9
Adamina Michel, Heberer M, Oertli D, Marti W R, Feder C, Reschner A, Schumacher R, Padovan E, Zajac P, Cavazza A, Albo F, Bolli M, Spagnoli G C
Immunothérapie active spécifique du mélanome
Adamina M. Immunothérapie active spécifique du mélanome. ecine & Hygiène 2004; 62:1225-1233.
Jan 1, 2004Immunothérapie active spécifique du mélanome
Jan 1, 2004ecine & Hygiène 2004; 62:1225-1233
Adamina Michel
Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina M, Marti W, Oertli D, Spagnoli G. Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients. Hum Gene Ther 2003; 14:1497-510.
Nov 1, 2003Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
Nov 1, 2003Hum Gene Ther 2003; 14:1497-510
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina Michel, Marti W, Oertli D, Spagnoli G
Prise en charge chirurgicale du nodule thyroïdien
Adamina M. Prise en charge chirurgicale du nodule thyroïdien. Médecine & Hygiène 2003; 61:1082-1087.
Jan 1, 2003Prise en charge chirurgicale du nodule thyroïdien
Jan 1, 2003Médecine & Hygiène 2003; 61:1082-1087
Adamina Michel
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Bolli M, Sauter G, Heberer M, Harder F, Gambazzi F, Mirlacher M, Haas P, Dalquen P, Guller U, Adamina M, Kocher T, Spagnoli G. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236:785-93; discussion 793.
Dec 1, 2002Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Dec 1, 2002Ann Surg 2002; 236:785-93; discussion 793
Bolli Martin, Sauter Guido, Heberer Michael, Harder Felix, Gambazzi Franco, Mirlacher Martina, Haas Philippe, Dalquen Peter, Guller Ulrich, Adamina Michel, Kocher Thomas, Spagnoli Giulio C
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Oertli D, Heberer M, Harder F, Schumacher R, Adamina M, Padovan E, Kocher T, Noppen C, Zajac P, Marti W, Spagnoli G. Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo. Hum Gene Ther 2002; 13:569-75.
Mar 1, 2002Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Mar 1, 2002Hum Gene Ther 2002; 13:569-75
Oertli Daniel, Heberer Michael, Harder Felix, Schumacher Reto, Adamina Michel, Padovan Elisabetta, Kocher Thomas, Noppen Christoph, Zajac Paul, Marti Walter R, Spagnoli Giulio C
Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Spagnoli G, Zajac P, Marti W, Oertli D, Padovan E, Noppen C, Kocher T, Adamina M, Heberer M. Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy. Recent Results Cancer Res 2002; 160:195-201.
Jan 1, 2002Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Jan 1, 2002Recent Results Cancer Res 2002; 160:195-201
Spagnoli Giulio C, Zajac Paul, Marti Walter R, Oertli Daniel, Padovan Elisabetta, Noppen Christoph, Kocher Thomas, Adamina Michel, Heberer Michael